Osteoarthritis Research Society International

What Osteoarthritis Research Society International does

The Osteoarthritis Research Society International (OARSI) is a private non-profit professional medical society founded in 1990 and headquartered in Mount Laurel, New Jersey. It is the leading international organization dedicated to osteoarthritis (OA) research, education, and knowledge dissemination, serving approximately 1,200 members from more than 50 countries, including basic, translational, and clinical researchers, physicians, rheumatologists, orthopedic surgeons, physiotherapists, and early-career investigators. OARSI is professionally managed by Association Headquarters, a charter-accredited association management company, and operates with a small team of four core staff (Executive Director, Senior Meeting Manager, Industry Relations Manager, Membership and Meeting Coordinator).

OARSI's core offerings include the peer-reviewed Osteoarthritis and Cartilage journal and its open-access companion Osteoarthritis and Cartilage Open, evidence-based clinical guidelines for non-surgical OA management, the annual World Congress on Osteoarthritis, the OARSI LIVE webinar series, two podcasts (Hey OA! and Joint Action), discussion groups, mentorship programs, and a resource library that includes infographics, white papers, and the OA Trial Bank. A notable strategic initiative is the Pre-Competitive Consortium for Osteoarthritis (PCCOA), which submitted a White Paper entitled 'Osteoarthritis as a Serious Disease' to the U.S. FDA in December 2016 (published 2018) to influence regulatory standards for structure-modifying OA therapies.

The society funds its operations through three recurring revenue streams: individual membership dues, event/congress registration fees, and corporate membership/sponsorship from nine industry partners spanning pharma, biotech, and clinical services (Pacira, Paradigm Biopharma, Serene LLC, Formation Bio, Seikagaku Corporation, Sun Pharma, Rottapharm Biotech, Arthritis Knee Pain Centers, and Moebius Medical). Pricing is not publicly disclosed. Revenue, financial statements, and headcount are not publicly disclosed; OARSI is independently governed by a Board of Directors with no parent company, private equity, or institutional investor ownership identified.

Name

Osteoarthritis Research Society International

Legal name

Osteoarthritis Research Society International, Inc.

Website

https://oarsi.org

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

OARSI is a private non-profit professional medical society founded in 1990 that serves 1,200+ osteoarthritis researchers and clinicians across 50+ countries through peer-reviewed journals, the annual World Congress, clinical guidelines, webinars, and corporate sponsorship programs.

Ownership category

akta.pro rank

Headquarters

HQ city

Mount Laurel

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Dues: Annual membership fees providing access to resources, networking, and member benefits
2. Event Registration: Revenue from World Congress and other educational events including conferences, seminars, and webinars
3. Corporate Membership/Sponsorship: Industry partners (Pacira, Paradigm Biopharma, Serene LLC, Formation Bio, Seikagaku Corporation, Sun Pharma, Rottapharm Biotech, Arthritis Knee Pain Centers, Moebius Medical) provide financial support through corporate membership tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

OARSI is a non-profit professional medical society that delivers peer-reviewed scientific journals, an annual international World Congress, clinical practice guidelines, webinars, podcasts, and educational resources for the global osteoarthritis research and clinical community. Its products and services are funded through individual membership dues, event registrations, and corporate sponsorships from pharmaceutical and medical device companies. The society operates as the leading international forum for OA-focused research presentation, collaboration, and knowledge dissemination.

Product overview

OARSI operates as a professional medical society offering a portfolio of scientific publications (Osteoarthritis and Cartilage Journal, Osteoarthritis and Cartilage Open), educational programming (OARSI LIVE webinars, Hey OA! Podcast, Joint Action Podcast), annual congresses, and clinical guidelines. The society serves as a hub for the global osteoarthritis research community with 1,200 members from more than 50 countries, providing resources for researchers, clinicians, and early career investigators through membership programs and professional development initiatives.

Differentiator

Problem solved

Functional benefit

Products and services

• Osteoarthritis and Cartilage Journal

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered major and minor.

• U.S. Food and Drug Administration (FDA)majorStrategic or Co-development Partner · 1 December 2016OARSI's Pre-Competitive Consortium for Osteoarthritis (PCCOA) submitted a White Paper entitled 'Osteoarthritis as a Serious Disease' to the FDA on December 1, 2016. The initiative aims to advance development of structure-modifying therapies and inform the drug approval process for new OA treatments.
• PaciraminorOthersCorporate member and supporter of OARSI, providing pharmaceutical solutions for pain management
• Paradigm BiopharmaminorOthersCorporate member supporting OARSI's mission in osteoarthritis research
• Serene LLCminorOthersCorporate member supporting OARSI's research and education initiatives
• Formation BiominorOthersCorporate member providing support for OARSI's global initiatives
• Seikagaku CorporationminorOthersCorporate member and supporter of OARSI
• Sun PharmaminorOthersCorporate member supporting OARSI's mission in osteoarthritis research
• Rottapharm BiotechminorOthersCorporate member supporting OARSI
• Arthritis Knee Pain CentersminorOthersCorporate member supporting OARSI's initiatives
• Moebius MedicalminorOthersCorporate member supporting OARSI's research efforts

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Regional players

• Asia Pacific League of Associations for Rheumatology (APLAR): Umbrella society for rheumatology associations across the Asia-Pacific region. APLAR's rheumatology research and education activities overlap with OARSI's mission and represent an alternative convening point for OA clinicians and researchers in the region.
• British Society for Rheumatology (BSR): U.K.-based rheumatology professional society that overlaps with OARSI on OA clinical guidelines, educational events, and journal readership. Comparable in mission to OARSI but geographically focused on the U.K. and Ireland.

Direct peers

• International Cartilage Regeneration & Joint Preservation Society (ICRS): International society dedicated to cartilage biology, repair, and joint preservation — directly overlapping with OARSI's cartilage and OA focus. ICRS is the most focused peer society on cartilage-focused OA research and competes for the same bench scientists.
• European Alliance of Associations for Rheumatology (EULAR): European counterpart to ACR, covering rheumatology research, education, and clinical guidelines. EULAR competes with OARSI for European members, annual congress attendance, and pharmaceutical sponsorship in the OA/inflammatory-arthritis space.
• International Osteoporosis Foundation (IOF): Global non-profit focused on osteoporosis and musculoskeletal health, with adjacent scope to OARSI. IOF offers a parallel model of industry-funded scientific society, congress, and clinical guidance targeting musculoskeletal disease — competing for related pharma sponsorships.
• Orthopaedic Research Society (ORS): International research society focused on musculoskeletal and orthopaedic research, with significant overlap in basic and translational OA science. ORS competes with OARSI for academic researchers, podium presentations, and society-level industry support.
• International Society of Orthopaedic Surgery and Traumatology (SICOT): International orthopaedic society spanning surgery and trauma, with an active research and education portfolio. SICOT overlaps with OARSI for orthopaedic clinician members and industry sponsors interested in joint-related research.
• American College of Rheumatology (ACR): Largest U.S. professional society for rheumatologists, with overlapping membership of clinicians treating OA. ACR publishes Arthritis & Rheumatology and issues clinical guidance that overlaps with OARSI's guidelines, making it a direct competitor for clinician attention, journal submissions, and industry sponsorship.

Broad incumbents

• Arthritis Foundation: U.S. patient-advocacy and research-funding organization covering all forms of arthritis, including OA. Although more advocacy-oriented than OARSI, the Arthritis Foundation overlaps on consumer education, fundraising, and industry partnerships related to OA.
• American Academy of Orthopaedic Surgeons (AAOS): Dominant U.S. orthopaedic surgery society with very broad scope. AAOS issues orthopaedic clinical practice guidelines that overlap with OARSI's non-surgical management guidelines and competes for industry sponsorship from orthopaedic implant and device companies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/oarsinews
• Facebookfacebook.com/osteoarthritisresearchsocietyinternational
• LinkedInlinkedin.com/company/osteoarthritis-research-scty

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Osteoarthritis Research Society International